180 related articles for article (PubMed ID: 376720)
1. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
[TBL] [Abstract][Full Text] [Related]
2. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
3. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
Boraschi D; Meltzer MS
J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
[No Abstract] [Full Text] [Related]
4. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
[No Abstract] [Full Text] [Related]
5. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
Ruco LP; Meltzer MS
J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
[TBL] [Abstract][Full Text] [Related]
6. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
7. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
8. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
Schafer R; Nacy CA; Eisenstein TK
J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
Nacy CA; Meltzer MS; Fortier AH
J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
[TBL] [Abstract][Full Text] [Related]
10. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
Varesio L
J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
[TBL] [Abstract][Full Text] [Related]
11. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
Poste G
Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
13. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
Adams DO; Marino PA; Meltzer MS
J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
15. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
Schultz RM; Chirigos MA
Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
Tomecki J; Sukiennik J; Kordowiak A
Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor efficacy of activated macrophages against murine glioma cells].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
